Skip to main content
. 2022 Mar 22;19(3):e1003959. doi: 10.1371/journal.pmed.1003959

Table 6. Review evidence certainty assessment (GRADE): Reduced clinical appointment frequency (6- or 12-monthly) versus 3-monthly clinical appointments.

Number of studies Certainty assessment Number of patients with outcome/number of patients total (%) Effect estimate: Risk ratio (95% CI) Certainty
Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations Reduced clinic appointment frequency 3-monthly clinic appointments
Retention in care among all enrolled at longest time point: Any reduced frequency versus 3-monthly clinic appointment frequency
8 RCTs & observational studies Seriousa Seriousb Not serious Not serious None 11,526/12,638 (91.2%) 8,454/9,623 (87.9%) 1.01 (0.97 to 1.04) ⨁⨁◯◯
Low
Retention in care among all enrolled at longest time point: RCTs
6 RCTs Not serious Seriousb Not serious Not serious None 9,892/10,759 (91.9%) 6,932/7,815 (88.7%) 1.00 (0.95 to 1.04) ⨁⨁⨁◯
Moderate
Retention in care among all enrolled at longest time point: Cohort studies
3 Observational studies Seriousc Not serious Not serious Not serious None 1,634/1,879 (87.0%) 1,522/1,808 (84.2%) 1.02 (0.97 to 1.09) ⨁◯◯◯
Very low
Retention in care among all enrolled at longest time point: 6-monthly versus 3-monthly clinic appointment frequency
4 RCTs & observational studies Seriousa Not serious Not serious Not serious None 2,602/3,013 (86.4%) 2,262/2,696 (83.9%) 1.03 (0.98 to 1.08) ⨁⨁⨁◯
Moderate
Retention in care among all enrolled at longest time point: 12-monthly versus 3-monthly clinic appointment frequency
4 RCTs Not serious Seriousb Not serious Not serious None 8,924/9,625 (92.7%) 6,192/6,927 (89.3%) 0.99 (0.94 to 1.04) ⨁⨁⨁◯
Moderate
Viral suppression among all enrolled at longest time point: RCTs
4 RCTs Very seriousd Seriousb Not serious Not serious None 3,424/6,801 (50.3%) 2,777/4,325 (64.2%) 0.74 (0.59 to 0.94) ⨁◯◯◯
Very low
Viral suppression among all enrolled at longest time point: Cohort studies
2 Observational studies Not serious Seriousb Not serious Not serious None 1,941/2,345 (82.8%) 2,934/6,729 (43.6%) 1.40 (0.95 to 2.08) ⨁◯◯◯
Very low
Viral suppression among all who received viral load testing at longest time point: RCTs
4 RCTs Not serious Seriousb Not serious Not serious None 3,424/3,489 (98.1%) 2,777/2,826 (98.3%) 1.00 (0.92 to 1.08) ⨁⨁⨁◯
Moderate
Viral suppression among all who received viral load testing at longest time point: Cohort studies
2 Observational studies Not serious Seriousb Not serious Not serious None 1,941/2,295 (84.6%) 2,934/2,962 (99.1%) 1.44 (1.24 to 1.66) ⨁◯◯◯
Very low
Mortality among all enrolled at longest time point: Any reduced frequency versus 3-monthly clinic appointment frequency
6 RCTs & observational studies Seriousa Not serious Not serious Very seriouse None 166/11,015 (1.5%) 101/7,810 (1.3%) 1.12 (0.75 to 1.66) ⨁◯◯◯
Very low
Mortality among all enrolled at longest time point: RCTs
5 RCTs Seriousd Not serious Not serious Very seriouse None 163/10,484 (1.6%) 100/7,521 (1.3%) 1.10 (0.73 to 1.65) ⨁⨁◯◯
Low
Mortality among all enrolled at longest time point: Cohort studies
1 Observational studies Seriousf Not serious Not serious Very seriouse None 3/531 (0.6%) 1/289 (0.3%) 1.63 (0.17 to 15.63) ⨁◯◯◯
Very low
Mortality among all enrolled at longest time point: 6-monthly versus 3-monthly clinic appointment frequency
2 RCTs & observational studies Seriousd Not serious Not serious Very seriouse None 120/1,390 (8.6%) 81/883 (9.2%) 1.05 (0.66 to 1.66) ⨁◯◯◯
Very low
Mortality among all enrolled at longest time point: 12-monthly versus 3-monthly clinic appointment frequency
4 RCTs Not serious Not serious Not serious Very seriouse None 46/9,625 (0.5%) 20/6,927 (0.3%) 1.35 (0.61 to 2.98) ⨁⨁◯◯
Low

CI, confidence interval; RCT, randomized controlled trial. Explanations

aCombination of cohort and RCT data. In addition, contributing observational study was ranked as poor quality.

bStatistical heterogeneity.

cVariable study quality.

dStudies with high risk of bias and/or some concerns of bias contribute substantially to estimate.

eDowngraded due to very wide confidence intervals including benefit and harm.

fEstimate consists of only 1 study.